Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178498 · ClinicalTrials.gov registry record
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
A clinical trial of Breast Carcinoma and Breast Lobular Carcinoma In Situ, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- 960
- Enrollment target
- 1
- Study location
NCT05178498 is a study of Breast Carcinoma and Breast Lobular Carcinoma In Situ that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 960 participants, above the 761-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05178498, a study of Breast Carcinoma and Breast Lobular Carcinoma In Situ, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 960 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Follow-Up
- PROCEDURE Physical Examination
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2023-10-25 |
| Est. Completion | 2035-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05178498
The ClinicalTrials.gov registry entry for NCT05178498 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 761-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (26% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05178498 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05178498 about?
NCT05178498 is a clinical study titled "Impact of Dietary Inflammatory Potential on Breast Cancer Risk". This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeu...
What is the current status of trial NCT05178498?
This trial is currently recruiting. The enrollment target is 960 participants. The study started on 2023-10-25. Estimated completion is 2035-12-31.
What conditions does trial NCT05178498 study?
This clinical trial studies the following conditions: Breast Carcinoma, Breast Lobular Carcinoma In Situ, Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Sclerosing Adenosis.
What interventions are being tested in trial NCT05178498?
The interventions under investigation include: Questionnaire Administration (OTHER), Follow-Up (PROCEDURE), Physical Examination (PROCEDURE).
Who is sponsoring clinical trial NCT05178498?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178498 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.